Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein.
about
Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophilsAdenovirus serotype 30 fiber does not mediate transduction via the coxsackie-adenovirus receptor.Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic ApplicationsStructural basis for variation in adenovirus affinity for the cellular coxsackievirus and adenovirus receptorIdentification of CD46 Binding Sites within the Adenovirus Serotype 35 Fiber KnobStructure of Reovirus σ1 in Complex with Its Receptor Junctional Adhesion Molecule-AThe GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitisDevelopment of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adaptersTraceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivoCell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interactionDefining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction In Vitro in the Presence of Mouse Serum.A strategy for adenovirus vector targeting with a secreted single chain antibody.Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway.Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells.Adenovirus receptors and their implications in gene deliveryCAR modulates E-cadherin dynamics in the presence of adenovirus type 5.Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.Development of a targeted gene vector platform based on simian adenovirus serotype 24.The promise and potential hazards of adenovirus gene therapy.Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.Survey of the year 2000 commercial optical biosensor literature.Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber.Mutation in fiber of adenovirus serotype 5 gene therapy vector decreases liver tropism.Penton-dodecahedral particles trigger opening of intercellular junctions and facilitate viral spread during adenovirus serotype 3 infection of epithelial cells.Adenovirus entry from the apical surface of polarized epithelia is facilitated by the host innate immune responseThe PDZ3 domain of the cellular scaffolding protein MAGI-1 interacts with the Coxsackievirus and adenovirus receptor (CAR).Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer TherapiesReduced infectivity of adenovirus type 5 particles and degradation of entering viral genomes associated with incomplete processing of the preterminal protein.Current advances and future challenges in Adenoviral vector biology and targetingNovel vectors for in vivo gene delivery to vascular tissue.TNFα promotes CAR-dependent migration of leukocytes across epithelial monolayers.Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responsesTargeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody.In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery.The role of the extracellular domain in the biology of the coxsackievirus and adenovirus receptor.Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies.Replacement of native adenovirus receptor-binding sites with a new attachment moiety diminishes hepatic tropism and enhances bioavailability in mice.Selection Pressure in the Human Adenovirus Fiber Knob Drives Cell Specificity in Epidemic Keratoconjunctivitis.An adenovirus traffic update: from receptor engagement to the nuclear pore.An update on canine adenovirus type 2 and its vectors.
P2860
Q24299261-FFB2FA8E-FA33-43A0-94CF-9583EFA814E1Q24538951-DBE182CF-E3AF-424E-8BD8-3FF2D8EF7C99Q26776553-E0A88E1D-8568-4BD4-8C85-09206F803984Q27641063-9D96AF47-95D9-4106-AE60-9C18504F2F61Q27648583-653DA201-C812-47A2-9B36-4F1A6EE2910FQ27653146-5D8E4E1B-AD5E-463B-B674-F4CE959E6872Q27666370-78B83518-AA92-4BF0-988B-E76566F0AE37Q27676519-5173EB81-572A-4BE2-ADE6-A8D9FF6F3973Q28539158-28F717F7-0E16-49E1-8BC8-24B0A5E22769Q28744246-0F726C98-7B80-4F3A-8F1A-454748D99525Q33440718-A022BB42-84C8-4566-956F-FA17DF75E618Q33520212-893B583A-68D2-4404-AE03-F5BF86DADB08Q33787309-303FEAFD-154D-4578-887E-AF0B44D90FA0Q33866165-1DE600BF-EA4C-443F-97D3-1C601146D2E6Q33994011-5BB50509-263C-4978-B652-F633E989D549Q33995638-058522D6-4DC2-4A24-8FA7-5A930FDAE45BQ34120709-7EA75CCA-9C22-4B1F-8B44-092336EBFE73Q34120794-665371E6-B4D6-4575-8D3C-CE157B96C9C2Q34219407-3DBF2C32-E03B-4635-BD12-C656F8B0395DQ34342665-096871F4-A642-4A7D-A655-F47DD2C9528FQ34464911-3421DD08-38CE-45CD-9114-D4BBE6DC594FQ34470809-8B40D7DB-C961-472F-B0DC-546E86554283Q35017003-DE473DA6-D306-41CA-AA88-9366B0249C4FQ35034232-D9D7478F-8247-4EBD-8FCF-F805981F00CCQ35175103-04B55B71-ABDE-4488-B639-5E05D818D847Q35178355-57F75C29-75BB-4FBC-86BB-A5F48309A448Q35641791-1A6A0886-1228-4F86-92ED-9EBAE2FEE910Q36414237-8798F3CA-B00B-483B-B25C-E742C57C182FQ36463004-A0175686-3EED-4467-BC69-2AE42F998003Q36842711-8D925D2F-D024-411A-A60D-D966D8CC6081Q36914535-499F417E-CCE4-4AF3-8C9E-D4EEFA8AC14FQ36954135-1FCCFB3A-91F3-4655-BFE6-7B25343AA77CQ37227135-6105D844-13AC-4F1D-8DA8-14BA0AD90209Q37232834-89212362-7438-417B-AFA7-A1ADE2B90B55Q37273865-84DAD5F3-347B-4FC9-925B-B3A040861519Q37317439-1D572F5A-E81F-4E94-AF8C-95F0726FCBB5Q37330624-F0DB5531-D9A5-48CC-9740-7A00102F759CQ37347285-58123B5A-9994-43F9-BFE6-83A5FC1EA548Q37848821-4942E18C-8756-4DB5-AECC-AF863B424503Q37945220-40F67620-F4DB-415B-8922-8D2FEDB24E32
P2860
Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Identification of contact resi ...... enovirus type 5 fiber protein.
@en
Identification of contact resi ...... enovirus type 5 fiber protein.
@nl
type
label
Identification of contact resi ...... enovirus type 5 fiber protein.
@en
Identification of contact resi ...... enovirus type 5 fiber protein.
@nl
prefLabel
Identification of contact resi ...... enovirus type 5 fiber protein.
@en
Identification of contact resi ...... enovirus type 5 fiber protein.
@nl
P2093
P2860
P1433
P1476
Identification of contact resi ...... enovirus type 5 fiber protein.
@en
P2093
A J Beavil
B J Sutton
P W Roelvink
T J Wickham
P2860
P304
P356
10.1128/JVI.74.6.2804-2813.2000
P407
P50
P577
2000-03-01T00:00:00Z